ID   PR15A_HUMAN             Reviewed;         674 AA.
AC   O75807; B4DKQ3; Q6IA96; Q9NVU6;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   22-JUL-2015, entry version 107.
DE   RecName: Full=Protein phosphatase 1 regulatory subunit 15A;
DE   AltName: Full=Growth arrest and DNA damage-inducible protein GADD34;
DE   AltName: Full=Myeloid differentiation primary response protein MyD116 homolog;
GN   Name=PPP1R15A; Synonyms=GADD34;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INDUCTION.
RX   PubMed=9153226; DOI=10.1074/jbc.272.21.13731;
RA   Hollander M.C., Zhan Q., Bae I., Fornace A.J. Jr.;
RT   "Mammalian GADD34, an apoptosis- and DNA damage-inducible gene.";
RL   J. Biol. Chem. 272:13731-13737(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   THR-32.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS GLU-277; SER-312; PRO-316; SER-476 AND ALA-597.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=8139541; DOI=10.1128/MCB.14.4.2361;
RA   Zhan Q., Lord K.A., Alamo I. Jr., Hollander M.C., Carrier F., Ron D.,
RA   Kohn K.W., Hoffman B., Liebermann D.A., Fornace A.J. Jr.;
RT   "The gadd and MyD genes define a novel set of mammalian genes encoding
RT   acidic proteins that synergistically suppress cell growth.";
RL   Mol. Cell. Biol. 14:2361-2371(1994).
RN   [7]
RP   INTERACTION WITH KMT2A/MLL1 AND SMARCB1, AND INDUCTION.
RX   PubMed=10490642;
RA   Adler H.T., Chinery R., Wu D.Y., Kussick S.J., Payne J.M.,
RA   Fornace A.J. Jr., Tkachuk D.C.;
RT   "Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and
RT   associate with the GADD34 and hSNF5/INI1 proteins.";
RL   Mol. Cell. Biol. 19:7050-7060(1999).
RN   [8]
RP   INTERACTION WITH LYN, AND PHOSPHORYLATION.
RX   PubMed=11517336; DOI=10.1073/pnas.191130798;
RA   Grishin A.V., Azhipa O., Semenov I., Corey S.J.;
RT   "Interaction between growth arrest-DNA damage protein 34 and Src
RT   kinase Lyn negatively regulates genotoxic apoptosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:10172-10177(2001).
RN   [9]
RP   INTERACTION WITH PP1 AND PPP1R1A, AND FUNCTION.
RX   PubMed=11564868; DOI=10.1128/MCB.21.20.6841-6850.2001;
RA   Connor J.H., Weiser D.C., Li S., Hallenbeck J.M., Shenolikar S.;
RT   "Growth arrest and DNA damage-inducible protein GADD34 assembles a
RT   novel signaling complex containing protein phosphatase 1 and inhibitor
RT   1.";
RL   Mol. Cell. Biol. 21:6841-6850(2001).
RN   [10]
RP   INTERACTION WITH SMARCB1 AND PP1, AND MUTAGENESIS OF 555-LYS--PHE-558.
RX   PubMed=12016208; DOI=10.1074/jbc.M200955200;
RA   Wu D.Y., Tkachuck D.C., Roberson R.S., Schubach W.H.;
RT   "The human SNF5/INI1 protein facilitates the function of the growth
RT   arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-
RT   bound protein phosphatase-1 activity.";
RL   J. Biol. Chem. 277:27706-27715(2002).
RN   [11]
RP   INDUCTION.
RX   PubMed=12114539; DOI=10.1073/pnas.152327199;
RA   Sarkar D., Su Z.-Z., Lebedeva I.V., Sauane M., Gopalkrishnan R.V.,
RA   Valerie K., Dent P., Fisher P.B.;
RT   "mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by
RT   inducing the coordinated overexpression of the GADD family of genes by
RT   means of p38 MAPK.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:10054-10059(2002).
RN   [12]
RP   FUNCTION.
RX   PubMed=14635196; DOI=10.1002/jcb.10711;
RA   Yagi A., Hasegawa Y., Xiao H., Haneda M., Kojima E., Nishikimi A.,
RA   Hasegawa T., Shimokata K., Isobe K.;
RT   "GADD34 induces p53 phosphorylation and p21/WAF1 transcription.";
RL   J. Cell. Biochem. 90:1242-1249(2003).
RN   [13]
RP   FUNCTION, MUTAGENESIS OF 556-VAL--SER-558; ARG-612; ARG-614 AND
RP   ARG-618, AND SUBCELLULAR LOCATION.
RX   PubMed=12556489; DOI=10.1128/MCB.23.4.1292-1303.2003;
RA   Brush M.H., Weiser D.C., Shenolikar S.;
RT   "Growth arrest and DNA damage-inducible protein GADD34 targets protein
RT   phosphatase 1 alpha to the endoplasmic reticulum and promotes
RT   dephosphorylation of the alpha subunit of eukaryotic translation
RT   initiation factor 2.";
RL   Mol. Cell. Biol. 23:1292-1303(2003).
RN   [14]
RP   INTERACTION WITH BAG1.
RX   PubMed=12724406; DOI=10.1128/MCB.23.10.3477-3486.2003;
RA   Hung W.J., Roberson R.S., Taft J., Wu D.Y.;
RT   "Human BAG-1 proteins bind to the cellular stress response protein
RT   GADD34 and interfere with GADD34 functions.";
RL   Mol. Cell. Biol. 23:3477-3486(2003).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH SMAD7.
RX   PubMed=14718519; DOI=10.1083/jcb.200307151;
RA   Shi W., Sun C., He B., Xiong W., Shi X., Yao D., Cao X.;
RT   "GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I
RT   receptor.";
RL   J. Cell Biol. 164:291-300(2004).
RN   [16]
RP   INTERACTION WITH PP1.
RX   PubMed=15705855; DOI=10.1126/science.1101902;
RA   Boyce M., Bryant K.F., Jousse C., Long K., Harding H.P., Scheuner D.,
RA   Kaufman R.J., Ma D., Coen D.M., Ron D., Yuan J.;
RT   "A selective inhibitor of eIF2alpha dephosphorylation protects cells
RT   from ER stress.";
RL   Science 307:935-939(2005).
RN   [17]
RP   SUBCELLULAR LOCATION, TOPOLOGY, INTRAMEMBRANE REGION, AND MUTAGENESIS
RP   OF VAL-25 AND LEU-29.
RX   PubMed=21518769; DOI=10.1074/jbc.M110.212787;
RA   Zhou W., Brush M.H., Choy M.S., Shenolikar S.;
RT   "Association with endoplasmic reticulum promotes proteasomal
RT   degradation of GADD34 protein.";
RL   J. Biol. Chem. 286:21687-21696(2011).
RN   [18]
RP   PHOSPHORYLATION AT TYR-262; TYR-391; TYR-434 AND TYR-512,
RP   UBIQUITINATION, AND MUTAGENESIS OF TYR-262.
RX   PubMed=24092754; DOI=10.1074/jbc.M113.504407;
RA   Zhou W., Jeyaraman K., Yusoff P., Shenolikar S.;
RT   "Phosphorylation at tyrosine 262 promotes GADD34 protein turnover.";
RL   J. Biol. Chem. 288:33146-33155(2013).
CC   -!- FUNCTION: Recruits the serine/threonine-protein phosphatase PP1 to
CC       dephosphorylate the translation initiation factor eIF-2A/EIF2S1,
CC       thereby reversing the shut-off of protein synthesis initiated by
CC       stress-inducible kinases and facilitating recovery of cells from
CC       stress. Down-regulates the TGF-beta signaling pathway by promoting
CC       dephosphorylation of TGFB1 by PP1. May promote apoptosis by
CC       inducing TP53 phosphorylation on 'Ser-15'.
CC       {ECO:0000269|PubMed:11564868, ECO:0000269|PubMed:12556489,
CC       ECO:0000269|PubMed:14635196, ECO:0000269|PubMed:14718519,
CC       ECO:0000269|PubMed:8139541}.
CC   -!- SUBUNIT: Interacts with PCNA (By similarity). Interacts with LYN
CC       and KMT2A/MLL1. Interacts with PP1, PPP1R1A and SMARCB1. Interacts
CC       with SMAD7. Interacts with BAG1. {ECO:0000250,
CC       ECO:0000269|PubMed:10490642, ECO:0000269|PubMed:11517336,
CC       ECO:0000269|PubMed:11564868, ECO:0000269|PubMed:12016208,
CC       ECO:0000269|PubMed:12724406, ECO:0000269|PubMed:14718519,
CC       ECO:0000269|PubMed:15705855}.
CC   -!- INTERACTION:
CC       P56545:CTBP2; NbExp=2; IntAct=EBI-714746, EBI-741533;
CC       Q13522:PPP1R1A; NbExp=4; IntAct=EBI-714746, EBI-1568511;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein; Cytoplasmic side {ECO:0000269|PubMed:12556489,
CC       ECO:0000269|PubMed:21518769}. Mitochondrion outer membrane;
CC       Peripheral membrane protein; Cytoplasmic side
CC       {ECO:0000269|PubMed:21518769}. Note=Associates with membranes via
CC       an N-terminal amphipathic intramembrane region.
CC       {ECO:0000269|PubMed:21518769}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75807-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75807-2; Sequence=VSP_057083, VSP_057084;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: By methyl methanesulfonate and ionizing irradiation. By
CC       IL24/interleukin-24 in melanoma cells; which induces apoptosis.
CC       {ECO:0000269|PubMed:10490642, ECO:0000269|PubMed:12114539,
CC       ECO:0000269|PubMed:9153226}.
CC   -!- PTM: Phosphorylated at multiple Ser/Thr residues. Phosphorylated
CC       on tyrosine by LYN; which impairs its antiproliferative activity.
CC       Phosphorylation at Tyr-262 enhances proteasomal degradation, this
CC       position is dephosphorylated by PTPN2.
CC       {ECO:0000269|PubMed:11517336, ECO:0000269|PubMed:24092754}.
CC   -!- PTM: Polyubiquitinated. Exhibits a rapid proteasomal degradation
CC       with a half-life under 1 hour, ubiquitination depends on
CC       endoplasmic reticulum association. {ECO:0000269|PubMed:24092754}.
CC   -!- MISCELLANEOUS: The phosphatase activity of the PPP1R15A-PP1
CC       complex toward EIF2S1 is specifically inhibited by Salubrinal, a
CC       drug that protects cells from endoplasmic reticulum stress.
CC   -!- SIMILARITY: Belongs to the PPP1R15 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U83981; AAC25631.1; -; mRNA.
DR   EMBL; CR457259; CAG33540.1; -; mRNA.
DR   EMBL; AK001361; BAA91649.1; -; mRNA.
DR   EMBL; AK296668; BAG59265.1; -; mRNA.
DR   EMBL; CH471177; EAW52409.1; -; Genomic_DNA.
DR   EMBL; BC003067; AAH03067.1; -; mRNA.
DR   CCDS; CCDS12738.1; -. [O75807-1]
DR   RefSeq; NP_055145.3; NM_014330.3. [O75807-1]
DR   UniGene; Hs.631593; -.
DR   ProteinModelPortal; O75807; -.
DR   BioGrid; 117172; 34.
DR   IntAct; O75807; 12.
DR   MINT; MINT-1192304; -.
DR   STRING; 9606.ENSP00000200453; -.
DR   PhosphoSite; O75807; -.
DR   BioMuta; PPP1R15A; -.
DR   MaxQB; O75807; -.
DR   PaxDb; O75807; -.
DR   PRIDE; O75807; -.
DR   DNASU; 23645; -.
DR   Ensembl; ENST00000200453; ENSP00000200453; ENSG00000087074.
DR   GeneID; 23645; -.
DR   KEGG; hsa:23645; -.
DR   UCSC; uc002pky.4; human. [O75807-1]
DR   CTD; 23645; -.
DR   GeneCards; GC19P049375; -.
DR   H-InvDB; HIX0015305; -.
DR   H-InvDB; HIX0174313; -.
DR   HGNC; HGNC:14375; PPP1R15A.
DR   HPA; CAB018395; -.
DR   HPA; HPA020240; -.
DR   MIM; 611048; gene.
DR   neXtProt; NX_O75807; -.
DR   PharmGKB; PA33632; -.
DR   eggNOG; NOG75356; -.
DR   GeneTree; ENSGT00510000049287; -.
DR   HOGENOM; HOG000060154; -.
DR   HOVERGEN; HBG052542; -.
DR   InParanoid; O75807; -.
DR   KO; K14019; -.
DR   OMA; VRAWVYR; -.
DR   OrthoDB; EOG75QR48; -.
DR   PhylomeDB; O75807; -.
DR   TreeFam; TF105547; -.
DR   Reactome; REACT_120727; Downregulation of TGF-beta receptor signaling.
DR   SignaLink; O75807; -.
DR   ChiTaRS; PPP1R15A; human.
DR   GeneWiki; PPP1R15A; -.
DR   GenomeRNAi; 23645; -.
DR   NextBio; 35472843; -.
DR   PRO; PR:O75807; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; O75807; -.
DR   CleanEx; HS_PPP1R15A; -.
DR   ExpressionAtlas; O75807; baseline and differential.
DR   Genevisible; O75807; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0016020; C:membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0000164; C:protein phosphatase type 1 complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0071862; F:protein phosphatase type 1 activator activity; IC:ParkinsonsUK-UCL.
DR   GO; GO:0008599; F:protein phosphatase type 1 regulator activity; IC:ParkinsonsUK-UCL.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:ProtInc.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; TAS:ProtInc.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:Ensembl.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; TAS:ParkinsonsUK-UCL.
DR   GO; GO:1903912; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; IEA:Ensembl.
DR   GO; GO:1903898; P:negative regulation of PERK-mediated unfolded protein response; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0032515; P:negative regulation of phosphoprotein phosphatase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1990441; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; IEA:Ensembl.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0070262; P:peptidyl-serine dephosphorylation; IEA:Ensembl.
DR   GO; GO:1903917; P:positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1902310; P:positive regulation of peptidyl-serine dephosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0045943; P:positive regulation of transcription from RNA polymerase I promoter; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0032058; P:positive regulation of translational initiation in response to stress; IC:ParkinsonsUK-UCL.
DR   GO; GO:0070972; P:protein localization to endoplasmic reticulum; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0060734; P:regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; IEA:Ensembl.
DR   GO; GO:0036496; P:regulation of translational initiation by eIF2 alpha dephosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   InterPro; IPR019523; Prot_Pase1_reg-su15A/B_C.
DR   Pfam; PF10488; PP1c_bdg; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Complete proteome;
KW   Endoplasmic reticulum; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Stress response; Translation regulation;
KW   Ubl conjugation.
FT   CHAIN         1    674       Protein phosphatase 1 regulatory subunit
FT                                15A.
FT                                /FTId=PRO_0000320518.
FT   TOPO_DOM      1     21       Cytoplasmic.
FT                                {ECO:0000305|PubMed:21518769}.
FT   INTRAMEM     22     39       Helical. {ECO:0000305|PubMed:21518769}.
FT   TOPO_DOM     40    674       Cytoplasmic.
FT                                {ECO:0000305|PubMed:21518769}.
FT   REPEAT      337    369       1.
FT   REPEAT      384    417       2.
FT   REPEAT      427    460       3.
FT   REPEAT      477    510       4.
FT   REGION        1     60       Required for localization in the
FT                                endoplasmic reticulum.
FT   REGION      337    510       4 X 34 AA approximate repeats.
FT   REGION      337    510       Interaction with SMAD7.
FT   REGION      483    555       Interaction with KMT2A/MLL1.
FT   REGION      536    583       Interaction with SMARCB1.
FT   COMPBIAS    112    115       Poly-Asp.
FT   COMPBIAS    160    503       Glu-rich.
FT   COMPBIAS    518    521       Poly-Pro.
FT   COMPBIAS    661    666       Poly-Ala.
FT   MOD_RES     262    262       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:24092754}.
FT   MOD_RES     391    391       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:24092754}.
FT   MOD_RES     434    434       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:24092754}.
FT   MOD_RES     512    512       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:24092754}.
FT   VAR_SEQ      16     16       A -> D (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057083.
FT   VAR_SEQ      17    175       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057084.
FT   VARIANT      31     31       R -> H (in dbSNP:rs564196).
FT                                /FTId=VAR_039186.
FT   VARIANT      32     32       A -> T (in dbSNP:rs3786734).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_039187.
FT   VARIANT     199    199       V -> A (in dbSNP:rs611251).
FT                                /FTId=VAR_039188.
FT   VARIANT     251    251       R -> P (in dbSNP:rs557806).
FT                                /FTId=VAR_039189.
FT   VARIANT     277    277       K -> E (in dbSNP:rs610308).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_039190.
FT   VARIANT     312    312       G -> S (in dbSNP:rs11541192).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_062226.
FT   VARIANT     316    316       A -> P (in dbSNP:rs556052).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_039191.
FT   VARIANT     381    381       A -> V (in dbSNP:rs1050166).
FT                                /FTId=VAR_039192.
FT   VARIANT     476    476       R -> S (in dbSNP:rs35087747).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_039193.
FT   VARIANT     594    594       R -> C (in dbSNP:rs2270946).
FT                                /FTId=VAR_039194.
FT   VARIANT     597    597       T -> A (in dbSNP:rs500079).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_039195.
FT   MUTAGEN      25     25       V->R: Localizes to cytoplasm, degraded
FT                                more slowly.
FT                                {ECO:0000269|PubMed:21518769}.
FT   MUTAGEN      29     29       L->R: Localizes to cytoplasm.
FT                                {ECO:0000269|PubMed:21518769}.
FT   MUTAGEN     262    262       Y->F: Significantly reduced turnover.
FT                                {ECO:0000269|PubMed:24092754}.
FT   MUTAGEN     555    558       KVRF->AAAA: Reduces interaction with
FT                                SMARCB1. {ECO:0000269|PubMed:12016208}.
FT   MUTAGEN     556    558       VRF->ARA: Impairs PP1 activation.
FT                                {ECO:0000269|PubMed:12556489}.
FT   MUTAGEN     612    612       R->K: Reduces PP1-binding; when
FT                                associated with K-614.
FT                                {ECO:0000269|PubMed:12556489}.
FT   MUTAGEN     614    614       R->K: Reduces PP1-binding; when
FT                                associated with K-612.
FT                                {ECO:0000269|PubMed:12556489}.
FT   MUTAGEN     618    618       R->D: Reduces PP1-binding.
FT                                {ECO:0000269|PubMed:12556489}.
FT   CONFLICT     80     80       E -> G (in Ref. 3; BAA91649).
FT                                {ECO:0000305}.
FT   CONFLICT    297    297       P -> L (in Ref. 2; CAG33540).
FT                                {ECO:0000305}.
FT   CONFLICT    669    669       L -> P (in Ref. 3; BAG59265).
FT                                {ECO:0000305}.
SQ   SEQUENCE   674 AA;  73478 MW;  B257AA17456D1403 CRC64;
     MAPGQAPHQA TPWRDAHPFF LLSPVMGLLS RAWSRLRGLG PLEPWLVEAV KGAALVEAGL
     EGEARTPLAI PHTPWGRRPE EEAEDSGGPG EDRETLGLKT SSSLPEAWGL LDDDDGMYGE
     REATSVPRGQ GSQFADGQRA PLSPSLLIRT LQGSDKNPGE EKAEEEGVAE EEGVNKFSYP
     PSHRECCPAV EEEDDEEAVK KEAHRTSTSA LSPGSKPSTW VSCPGEEENQ ATEDKRTERS
     KGARKTSVSP RSSGSDPRSW EYRSGEASEE KEEKAHKETG KGEAAPGPQS SAPAQRPQLK
     SWWCQPSDEE EGEVKALGAA EKDGEAECPP CIPPPSAFLK AWVYWPGEDT EEEEDEEEDE
     DSDSGSDEEE GEAEASSSTP ATGVFLKSWV YQPGEDTEEE EDEDSDTGSA EDEREAETSA
     STPPASAFLK AWVYRPGEDT EEEEDEDVDS EDKEDDSEAA LGEAESDPHP SHPDQRAHFR
     GWGYRPGKET EEEEAAEDWG EAEPCPFRVA IYVPGEKPPP PWAPPRLPLR LQRRLKRPET
     PTHDPDPETP LKARKVRFSE KVTVHFLAVW AGPAQAARQG PWEQLARDRS RFARRITQAQ
     EELSPCLTPA ARARAWARLR NPPLAPIPAL TQTLPSSSVP SSPVQTTPLS QAVATPSRSS
     AAAAAALDLS GRRG
//
